MedTrace Logo

Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients

NCT00005918 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 730

Last updated 2011-05-04

No results posted yet for this study

Summary

The purpose of this study is to compare the safety and effectiveness of 2 forms of stavudine (d4T). One form is taken once a day (extended release) and the other form is taken twice a day (immediate release).

Conditions

  • HIV Infections

Interventions

DRUG

Efavirenz

DRUG

Lamivudine

DRUG

Stavudine

Sponsors & Collaborators

Study Design

Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-06-30
Primary Completion
2002-04-30
Completion
2002-04-30

Countries

  • United States
  • Argentina
  • Australia
  • Belgium
  • Brazil
  • Canada
  • France
  • Israel
  • Italy
  • Mexico
  • Portugal
  • Puerto Rico
  • Russia
  • South Africa
  • Spain
  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005918 on ClinicalTrials.gov